Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ludwig

Showing results (411-420 of 500) with videos related to

Pageof 50
Sort By:
Genes, Chromosomes & Cancer|August 31, 2004
Emergence of translocation t(9;11)-positive leukemia during treatment of childhood acute lymphoblastic leukemiaMarkus Metzler, Pamela L Strissel, Reiner Strick, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 9, 2022
Evaluation of lesion and overlying articular cartilage in patients with juvenile osteochondritis dissecans of the knee using quantitative diffusion MRIŠtefan Zbýň, Abdul Wahed Kajabi, Cyrus M Nouraee, et al.
Clinical Immunology (Orlando, Fla.)|November 6, 2020
Laboratory biomarkers associated with COVID-19 severity and managementS Keddie, O Ziff, M K L Chou, et al.
Blood|June 11, 1999
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative GroupT Büchner, W Hiddemann, B Wörmann, et al.
Leukemia|January 26, 2005
Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALLG K Przybylski, W A Dik, J Wanzeck, et al.
Leukemia|June 1, 1996
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92S Schlieben, A Borkhardt, I Reinisch, et al.
Blood|November 24, 1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90A Reiter, M Schrappe, M Tiemann, et al.
Leukemia & Lymphoma|October 1, 1996
Acute myeloid leukemia with translocation (8;21). Cytomorphology, dysplasia and prognostic factors in 41 cases. AML Cooperative Group and ECOGT Haferlach, J M Bennett, H Löffler, et al.
Medical and Pediatric Oncology|May 2, 2002
In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study GroupsN L Ramakers-van Woerden, R Pieters, D Hoelzer, et al.
Molecular Cancer Therapeutics|August 13, 2009
Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastomaSanjeev A Vasudevan, Xiaoying Shang, Xiaoyi Shang, et al.
Pageof 50

Showing results (411-420 of 500) with videos related to

Sort By:
Pageof 50
Genes, Chromosomes & Cancer|August 31, 2004
Emergence of translocation t(9;11)-positive leukemia during treatment of childhood acute lymphoblastic leukemiaMarkus Metzler, Pamela L Strissel, Reiner Strick, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 9, 2022
Evaluation of lesion and overlying articular cartilage in patients with juvenile osteochondritis dissecans of the knee using quantitative diffusion MRIŠtefan Zbýň, Abdul Wahed Kajabi, Cyrus M Nouraee, et al.
Clinical Immunology (Orlando, Fla.)|November 6, 2020
Laboratory biomarkers associated with COVID-19 severity and managementS Keddie, O Ziff, M K L Chou, et al.
Blood|June 11, 1999
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative GroupT Büchner, W Hiddemann, B Wörmann, et al.
Leukemia|January 26, 2005
Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALLG K Przybylski, W A Dik, J Wanzeck, et al.
Leukemia|June 1, 1996
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92S Schlieben, A Borkhardt, I Reinisch, et al.
Blood|November 24, 1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90A Reiter, M Schrappe, M Tiemann, et al.
Leukemia & Lymphoma|October 1, 1996
Acute myeloid leukemia with translocation (8;21). Cytomorphology, dysplasia and prognostic factors in 41 cases. AML Cooperative Group and ECOGT Haferlach, J M Bennett, H Löffler, et al.
Medical and Pediatric Oncology|May 2, 2002
In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study GroupsN L Ramakers-van Woerden, R Pieters, D Hoelzer, et al.
Molecular Cancer Therapeutics|August 13, 2009
Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastomaSanjeev A Vasudevan, Xiaoying Shang, Xiaoyi Shang, et al.
Pageof 50